Glen A. Farmer serves as Executive at Immune Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Glen A. Farmer has executed 1 insider transactions totaling $20.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 10, 2023 involved purchasing 409,000 shares valued at $20.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 10, 2023 | IMUN | $20.4K | Purchase | 409,000 | $0.05 | Discretionary |
Glen A. Farmer currently holds 409,000 shares of Immune Therapeutics, Inc. (IMUN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glen A. Farmer has been a net buyer of IMUN stock. They have purchased $20.4K and sold $0 worth of shares.
Glen A. Farmer's most recent insider trade was on Feb 10, 2023, when they purchased 409,000 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted